# REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease

> **NCT06936111** · — · RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 900 (estimated)

## Conditions studied

- Coronary Heart Disease (CHD)

## Interventions

- **DIAGNOSTIC_TEST:** Assessment of residual cholesterol and inflammatory risk factors

## Key facts

- **NCT ID:** NCT06936111
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-07
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06936111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06936111, "REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06936111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*